Methods of treating ulcerative colitis with an anti-IL-23p19 antibody
US12152072B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2019 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Dec 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to the treatment of ulcerative colitis with an anti-IL-23p19 antibody, in particular dosage regimens for the treatment of the disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.